Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hirayama

Showing results (61-70 of 129) with videos related to

Pageof 13
Sort By:
Life Sciences|May 15, 2002
Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptorsN Shibuya-Fujiwara, F Hirayama, Y Ogata, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996
Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cellsY Yonemura, H Ku, F Hirayama, et al.
European Journal of Pharmacology|February 24, 1998
YM-60828, a novel factor Xa inhibitor: separation of its antithrombotic effects from its prolongation of bleeding timeK Sato, T Kawasaki, Y Taniuchi, et al.
Journal of Pharmaceutical Sciences|March 1, 1984
Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phasesK Uekama, F Hirayama, A Fujise, et al.
Chemical & Pharmaceutical Bulletin|September 19, 2000
Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution propertiesT Yamada, T Imai, K Ouchi, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1982
Effect of cyclodextrins on the acid hydrolysis of digoxinK Uekama, T Fujinaga, F Hirayama, et al.
Journal of Pharmaceutical Sciences|March 1, 1990
Design and in vitro evaluation of slow-release dosage form of piretanide: utility of beta-cyclodextrin:cellulose derivative combination as a modified-release drug carrierK Uekama, K Matsubara, K Abe, et al.
Journal of Pharmaceutical Sciences|March 1, 1988
Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrateF Hirayama, N Hirashima, K Abe, et al.
Journal of Pharmaceutical Sciences|May 18, 2001
Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in ratsH Arima, K Yunomae, K Miyake, et al.
Immunohematology|March 28, 2006
A single base insertion of the 4-alpha-galactosyltransferase gene led to the deficiency of Gb3 biosynthesisM Tanaka, N Yamashita, J Takahashi, et al.
Pageof 13

Showing results (61-70 of 129) with videos related to

Sort By:
Pageof 13
Life Sciences|May 15, 2002
Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptorsN Shibuya-Fujiwara, F Hirayama, Y Ogata, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 1996
Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cellsY Yonemura, H Ku, F Hirayama, et al.
European Journal of Pharmacology|February 24, 1998
YM-60828, a novel factor Xa inhibitor: separation of its antithrombotic effects from its prolongation of bleeding timeK Sato, T Kawasaki, Y Taniuchi, et al.
Journal of Pharmaceutical Sciences|March 1, 1984
Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phasesK Uekama, F Hirayama, A Fujise, et al.
Chemical & Pharmaceutical Bulletin|September 19, 2000
Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution propertiesT Yamada, T Imai, K Ouchi, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1982
Effect of cyclodextrins on the acid hydrolysis of digoxinK Uekama, T Fujinaga, F Hirayama, et al.
Journal of Pharmaceutical Sciences|March 1, 1990
Design and in vitro evaluation of slow-release dosage form of piretanide: utility of beta-cyclodextrin:cellulose derivative combination as a modified-release drug carrierK Uekama, K Matsubara, K Abe, et al.
Journal of Pharmaceutical Sciences|March 1, 1988
Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrateF Hirayama, N Hirashima, K Abe, et al.
Journal of Pharmaceutical Sciences|May 18, 2001
Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in ratsH Arima, K Yunomae, K Miyake, et al.
Immunohematology|March 28, 2006
A single base insertion of the 4-alpha-galactosyltransferase gene led to the deficiency of Gb3 biosynthesisM Tanaka, N Yamashita, J Takahashi, et al.
Pageof 13